Harvard Bioscience (HBIO) Intangibles (2010 - 2026)

Harvard Bioscience (HBIO) has 17 years of Intangibles data on file, last reported at $6.9 million in Q1 2026.

• Intangibles for Q1 2026 came in at $6.9 million, up 3318.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.9 million (up 3318.81% YoY), and the FY2025 annual result was $60.5 million, up 3.52% from the prior year.
• Intangibles eased to $6.9 million in Q1 2026 per HBIO's latest filing, from $60.5 million in the prior quarter.
• Over five years, Intangibles peaked at $63.7 million in Q2 2022 and troughed at $202000.0 in Q1 2023.
• A 5-year average of $25.0 million and a median of $13.4 million in 2024 frame the typical range for Intangibles.
• The sharpest annual moves came in 2022 and 2024: Intangibles slumped 99.68% in 2022, then jumped 28777.72% in 2024.
• A 5-year view of Intangibles shows it stood at $224000.0 in 2022, then soared by 7058.93% to $16.0 million in 2023, then soared by 264.5% to $58.5 million in 2024, then advanced by 3.52% to $60.5 million in 2025, then tumbled by 88.59% to $6.9 million in 2026.
• Business Quant data shows HBIO's Intangibles at $6.9 million in Q1 2026, $60.5 million in Q4 2025, and $218000.0 in Q3 2025.